Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes

Michael A. Via, Himani Chandra, Takako Araki, Matthew V. Potenza, Maria Skamagas

Research output: Contribution to journal › Review article › peer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences